Date | Title | Description |
25.02.2025 | Pharming Technologies B.V. announces a supplement to the offer document in respect of the recommended cash offer to the shareholders of Abliva AB (publ) | Pharming Technologies B.V. announces a supplement to the offer document in respect of the recommended cash offer to the shareholders of Abliva AB (publ)
Tue, Feb 25, 2025 16:30 CET Report this content
This press release is not an offer, whe... |
11.02.2025 | DNB Markets: Strongest ever quarter | DNB Markets: Strongest ever quarter
Tue, Feb 11, 2025 17:01 CET Report this content
IAR’s Q4 results were strong across the board despite tough YOY comparables, with encouraging early signals of commercial traction for its SaaS offering and... |
30.01.2025 | Pharming Technologies B.V. has received the necessary regulatory approval for the recommended cash offer to the shareholders of Abliva AB (publ) | Pharming Technologies B.V. has received the necessary regulatory approval for the recommended cash offer to the shareholders of Abliva AB (publ)
Thu, Jan 30, 2025 12:00 CET Report this content
This press release is not an offer, whether dir... |
16.01.2025 | Pharming Technologies Targets Abliva: A Strategic Cash Offer Unfolds | In the world of pharmaceuticals, mergers and acquisitions are like chess games. Each move is calculated, each piece strategically placed. On January 15, 2025, Pharming Technologies B.V. made a bold move by announcing a cash offer for Abliva... |
15.01.2025 | Offer document regarding Pharming Technologies B.V.’s recommended cash offer to the shareholders of Abliva AB (publ) | Offer document regarding Pharming Technologies B.V.’s recommended cash offer to the shareholders of Abliva AB (publ)
Wed, Jan 15, 2025 10:40 CET Report this content
This press release is not an offer, whether directly or indirectly, in Aust... |
05.11.2024 | Strategic Value Partners, LLC, through Coniferous Bidco AB, publishes offer document regarding the cash offer to the shareholders of Nordic Paper Holding AB | Strategic Value Partners, LLC, through Coniferous Bidco AB, publishes offer document regarding the cash offer to the shareholders of Nordic Paper Holding AB
Tue, Nov 05, 2024 10:30 CET Report this content
This announcement is not an offer, ... |
24.04.2024 | DNB Markets – Episurf Medical: New US distributor agreement | DNB Markets – Episurf Medical: New US distributor agreement
Wed, Apr 24, 2024 17:19 CET Report this content
Episurf Medical reported Q1 earnings (loss) broadly in line with our expectation, despite somewhat lower sales. While it seems to ha... |
13.02.2024 | DNB Markets – Episurf Medical: Sales moving in the right direction | DNB Markets – Episurf Medical: Sales moving in the right direction
Tue, Feb 13, 2024 08:47 CET Report this content
Q4 sales were in line with our forecast, but operating expenses were higher. Overall, we believe sales growth will be the mos... |
15.01.2024 | Thomson Reuters publishes supplement to the offer document in respect of the recommended public offer to the shareholders of Pagero | Thomson Reuters publishes supplement to the offer document in respect of the recommended public offer to the shareholders of Pagero
Mon, Jan 15, 2024 10:00 CET Report this content
The Offer is not being made, and this press release may not ... |
26.10.2023 | DNB Markets: VEF - Mixed signals | DNB Markets: VEF - Mixed signals
Thu, Oct 26, 2023 05:56 CET Report this content
VEF marked down its portfolio by 13% QOQ in Q3, putting YTD NAV growth at 11% (in USD), still lagging behind its portfolio peers (up 20–80% in USD). Its share ... |
19.10.2023 | Elos Medtech publishes prospectus for the rights issue and updates timetable | Elos Medtech publishes prospectus for the rights issue and updates timetable
Thu, Oct 19, 2023 09:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED S... |
17.08.2023 | DNB Markets - IAR Systems: Potential for share buy backs | DNB Markets - IAR Systems: Potential for share buy backs
Thu, Aug 17, 2023 20:32 CET Report this content
The modernisation of IAR Systems continues in full force. Having laid off 11% of its employees, launched its new integrated safety, sec... |
20.07.2023 | DNB Markets - VEF: Green shoots | DNB Markets - VEF: Green shoots
Thu, Jul 20, 2023 07:59 CET Report this content
VEF's share price is down 12% in SEK YTD despite: 1) a 25% recovery in its NAV YTD (in USD), which lags green shoots from its portfolio peers (up 30–70% in USD)... |
24.04.2023 | DNB Markets - Nexam Chemical: Still waiting for Chemical Romance | DNB Markets - Nexam Chemical: Still waiting for Chemical Romance
Mon, Apr 24, 2023 13:44 CET Report this content
Q1 sales were c13% below our forecast, driven by weaker sales growth in Performance Chemical than we expected. On a positive no... |
20.04.2023 | DNB Markets: VEF - Continues to play defence | DNB Markets: VEF - Continues to play defence
Thu, Apr 20, 2023 07:15 CET Report this content
VEF has taken a conservative stance on its NAV while adjusting its holdings growth strategies through 2022–2023, with cash available equal to 11% o... |
10.02.2023 | DNB Markets - IAR Systems: Dent in turnaround trajectory | DNB Markets - IAR Systems: Dent in turnaround trajectory
Fri, Feb 10, 2023 07:28 CET Report this content
IAR Systems’ Q4 report was a slight hiccup in its accelerated profitable growth turnaround, but we still expect it to see 45%+ EBIT gro... |
30.01.2023 | DNB Markets - Nexam Chemical: Still waiting for wind of change | DNB Markets - Nexam Chemical: Still waiting for wind of change
Mon, Jan 30, 2023 19:30 CET Report this content
For yet another quarter, Nexam was hurt by slow demand in the wind power industry. However, sales for other parts of the Performa... |
26.01.2023 | DNB Markets: VEF - High veta if market mood shifts | DNB Markets: VEF - High veta if market mood shifts
Thu, Jan 26, 2023 09:04 CET Report this content
VEF took a defensive stance in 2022, focusing on strengthening its balance sheet and reprioritising growth strategies across its portfolio, w... |
19.11.2022 | DNB Markets - Episurf Medical: CMD and Q3 results | DNB Markets - Episurf Medical: CMD and Q3 results
Sat, Nov 19, 2022 12:36 CET Report this content
Episurf Medical hosted a CMD on 16 November at which it discussed the state of the company and its long-term plans. International expansion wi... |
28.10.2022 | DNB Markets - IAR Systems: First glimpse of security traction | DNB Markets - IAR Systems: First glimpse of security traction
Fri, Oct 28, 2022 07:58 CET Report this content
Delving into the Q3 results, we note adj. EBIT grew 41% YOY (in line with our forecast), lending credence to our case that IAR is ... |
27.10.2022 | DNB Markets - VEF: Starting to lean forward again | DNB Markets - VEF: Starting to lean forward again
Thu, Oct 27, 2022 07:06 CET Report this content
VEF continues to trade below pre-covid levels at a 40% discount to reported NAV (58% to our estimated NAV). We believe the ice-cold winds blow... |
02.09.2022 | DNB Markets - IAR Systems: Trending in the right direction | DNB Markets - IAR Systems: Trending in the right direction
Fri, Sep 02, 2022 09:42 CET Report this content
A quality Q2 beat reinforces our view that IAR Systems is gradually coming back to an accelerated profitable growth trajectory after ... |
04.08.2022 | DNB Markets – Isofol Medical: AGENT phase III trial fails | DNB Markets – Isofol Medical: AGENT phase III trial fails
Thu, Aug 04, 2022 16:43 CET Report this content
Isofol Medical announced that the phase III trial AGENT had failed to reach its primary and most important secondary endpoints. This i... |
20.07.2022 | DNB Markets - VEF: This too shall pass | DNB Markets - VEF: This too shall pass
Wed, Jul 20, 2022 20:01 CET Report this content
VEF’s Q2 NAV fell 40% QOQ, which we believe reflects conservatism from VEF, as its largest asset, Creditas, recently received funding from new investors ... |
18.07.2022 | DNB Markets - Episurf: Episealer adoption is accelerating | DNB Markets - Episurf: Episealer adoption is accelerating
Mon, Jul 18, 2022 17:46 CET Report this content
Although Episurf Medical has a long way to go until the Episealer implant system is fully established as a core treatment option, we b... |
14.06.2022 | DNB Markets – Nelly: Profitability has to wait | DNB Markets – Nelly: Profitability has to wait
Tue, Jun 14, 2022 15:11 CET Report this content
Nelly issued a profit warning for Q2 last week. Despite a higher gross margin and lower warehousing costs, operating profit has been decreasing i... |
16.05.2022 | DNB Markets – Isofol Medical: Approaching AGENT read-out | DNB Markets – Isofol Medical: Approaching AGENT read-out
Mon, May 16, 2022 17:36 CET Report this content
In our view, the Q1 report was a non-event, with the results broadly in line with our estimates. The company continued its dialogue wit... |
28.04.2022 | DNB Markets - VEF: Market volatility not new to VEF | DNB Markets - VEF: Market volatility not new to VEF
Thu, Apr 28, 2022 07:55 CET Report this content
VEF’s NAV declined only ~3% QOQ in Q1 despite turbulent markets. With a portfolio of leading fintech holdings across some of the world’s fas... |
27.04.2022 | DNB Markets - IAR Systems: Sensing improvements | DNB Markets - IAR Systems: Sensing improvements
Wed, Apr 27, 2022 07:52 CET Report this content
Despite its exposure to high-growth megatrends, such as IoT and cybersecurity, overall revenue growth for IAR Systems’ programming tools has bee... |
25.04.2022 | DNB Markets - Nexam Chemical: Short-term pain, long-term gain | DNB Markets - Nexam Chemical: Short-term pain, long-term gain
Mon, Apr 25, 2022 09:45 CET Report this content
We have lowered our 2022e sales by 9% following a weaker short-term outlook for wind power. We find the company’s implicit 2022 sa... |
22.03.2022 | Baseload Capital Attends CERAWeek - The World's Premier Energy Event | Baseload Capital Attends CERAWeek - The World's Premier Energy Event
Tue, Mar 22, 2022 07:30 CET Report this content
Baseload Capital was a featured speaker at this year's CERAWeek – The World's Premier Energy Event. For forty years, CERAWe... |
02.03.2022 | DNB Markets - Isofol Medical: Waiting for AGENT read-out | DNB Markets - Isofol Medical: Waiting for AGENT read-out
Wed, Mar 02, 2022 08:00 CET Report this content
Isofol Medical released its Q4 report on 24 February. The report was a non-event, in our view. In Q4, the company announced that it wou... |
15.02.2022 | DNB Markets - IAR Systems: Ripping off the sticking plaster | DNB Markets - IAR Systems: Ripping off the sticking plaster
Tue, Feb 15, 2022 07:44 CET Report this content
Although we do not expect results overnight, we believe IAR Systems is taking the steps needed to get moving in the right direction ... |
14.02.2022 | DNB Markets - Episurf Medical: Looking past Covid-19 | DNB Markets - Episurf Medical: Looking past Covid-19
Mon, Feb 14, 2022 07:52 CET Report this content
Q4 was clearly hit by Covid-19, but we expect things to improve over the coming quarters (although Q1 might still see some negative impact)... |
03.02.2022 | DNB Markets: VEF - Trading 21% below NAV | DNB Markets: VEF - Trading 21% below NAV
Thu, Feb 03, 2022 07:40 CET Report this content
VEF continued the strong 30%+ NAVPS CAGR seen over the past six years, while its share price appears to have decoupled from NAV: it is trading 21% belo... |
03.11.2021 | DNB Markets - VEF: Many shots at goal | DNB Markets - VEF: Many shots at goal Wed, Nov 03, 2021 18:22 CET
VEF is increasingly getting recognition for its impressive 5-year NAVPS CAGR and rare emerging market VC fintech portfolio, in our view, with its discount to reported NAV rev... |
28.10.2021 | DNB Markets - IAR Systems: Winds of change | DNB Markets - IAR Systems: Winds of change Thu, Oct 28, 2021 07:29 CET
IAR Systems is trading at a 2022e EV/EBIT of 12x. Although the recent CEO dismissal could cloud short-term operational momentum, we believe it could signal a turning poi... |
18.08.2021 | DNB Markets - IAR Systems: Resetting expectations on security | DNB Markets - IAR Systems: Resetting expectations on security Wed, Aug 18, 2021 07:36 CET
We have lowered our 2021–2022e EPS by c15% to reflect the slower ramp-up of IoT security. Challenges remain, but as customer behaviour normalises, wit... |
29.07.2021 | DNB Markets: VEF - On track with more expected | DNB Markets: VEF - On track with more expected Thu, Jul 29, 2021 07:53 CET
VEF’s 30%+ NAV CAGR track record and improved ESG assessment have become increasingly credited by the investment community as its discount to NAV has eroded in recen... |
04.06.2021 | Aros Bostad announces offering of ordinary shares and publishes a prospectus in connection with the listing on Nasdaq First North Growth Market | Aros Bostad announces offering of ordinary shares and publishes a prospectus in connection with the listing on Nasdaq First North Growth Market Fri, Jun 04, 2021 15:30 CET
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIREC... |
19.05.2021 | BIOSERGEN INTENDS TO LIST ITS SHARES ON NASDAQ FIRST NORTH GROWTH MARKET STOCKHOLM | BIOSERGEN INTENDS TO LIST ITS SHARES ON NASDAQ FIRST NORTH GROWTH MARKET STOCKHOLM Wed, May 19, 2021 14:00 CET
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRAL... |